title: Oxytocin treatment immediately after calving does not reduce the incidence of retained fetal membranes or improve reproductive performance in crossbred Zebu cows.
abstract: The objective was to determine the effect of oxytocin treatments after calving on the incidence of RFM and reproductive performance in dual purpose cows under tropical conditions. Five hundred thirty six pluriparous, crossbred Zebu cows were randomly assigned to two groups: Oxy (n = 280): cows were given 30 IU of oxytocin im immediately after normal unassisted calving, and again 6 h later; C (n = 256): control. Expulsion of fetal membranes was evaluated 24 h after delivery. After a 30-d voluntary waiting period, AI was done 12 h after cows were detected in estrus. Oxytocin had no effect on the incidence of RFM (4.6 vs. 3.1% for Oxy and C, respectively, P > 0.05). Cows in Oxy and C had similar first service and overall pregnancy rates (54.0 vs. 47.8% and 75.4 vs. 73.4%; respectively, P > 0.05). There were no differences between Oxy and C for calving to first estrus (83.6 ± 3.7 vs. 77.2 ± 3.8 d) and calving to conception intervals (113.6 ± 5.0 vs. 110.5 ± 5.2 d), as well as rates of anestrus (13.6 vs. 13.7%), repeat breeding (21.8 vs. 20.7%), and culling (15.7 vs. 16.4%). In conclusion, oxytocin treatment after normal unassisted calving did not significantly reduce the incidence of RFM or improve reproductive performance in crossbred Zebu cows under tropical conditions.
authors: Unidad de Investigación en Reproducción Animal, Facultad de Ciencias Veterinarias, Universidad del Zulia, Maracaibo, Venezuela. palomnr@auburn.edu
authors: R A
authors: RA
authors: Palomares
authors: J C
authors: JC
authors: Gutiérrez
authors: G
authors: G
authors: Portillo
authors: J C
authors: JC
authors: Boscan
authors: M
authors: M
authors: Montero
authors: Y
authors: Y
authors: López
authors: H S
authors: HS
authors: Maxwell
authors: R L
authors: RL
authors: Carson
authors: E
authors: E
authors: Soto
mesh_terms: D000818:Animals; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D006824:Hybridization, Genetic; D015994:Incidence; D010121:Oxytocin / Q000627:therapeutic use*; D018457:Placenta, Retained / Q000188:drug therapy / Q000453:epidemiology / Q000662:veterinary*; D049590:Postpartum Period; D011247:Pregnancy; D018873:Pregnancy Rate
chemical_list: D010121:Oxytocin